PEVPRIA
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Apr 2024)
What this means for you
This application is over — abandoned 15 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97596512
- Mark type
- Stylized text
- Filed
- 19 Sept 2022
- Published for opposition
- 17 Jan 2023
- Abandoned
- 15 Apr 2024
- Attorney of record
- Richard A. Friedman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, anti-fungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
Owner
- Hospira, Inc., Lake Forest, IL, US
- Hospira, Inc., Lake Forest, IL, US
Prosecution history
- 15 Apr 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Apr 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Aug 2023 — SOU EXTENSION 1 GRANTED
- 02 Aug 2023 — SOU EXTENSION 1 FILED
- 02 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 14 Mar 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jan 2023 — PUBLISHED FOR OPPOSITION
- 28 Dec 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Dec 2022 — ASSIGNED TO EXAMINER
- 04 Oct 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Sept 2022 — NEW APPLICATION ENTERED